Agenda
Friday, March 20, 2026
8:00 am - 3:10 pm EDT
Virtual
*Agenda reflects invited speakers
Log in to Virtual Conference
Welcome and Opening Remarks
Naomi Haas, MD | Hematology Oncology | Conference Chair
Glenn Sykes | Cancer Patient Advocate | Conference Co-Chair
News from the Abramson Cancer Center
Rhiannon Nolt | Penn Medicine Development
GENERAL SESSION 1: I HAVE BEEN RECENTLY DIAGNOSED, NOW WHAT?
Kidney Cancer Risk Stratification, Surgery, and Other Local Treatment Option
Daniel Lee, MD, MS | Urology | Conference Co-Chair
After Kidney Surgery, What Is My Risk of Recurrence, and Can I Do Anything to Prevent It?
Vivek Narayan, MD, MS | Hematology Oncology | Conference Co-Chair
How Do I Care for My Remaining Kidney After Surgery?
Aisha Shaikh, MBBS | Renal-Electrolyte and Hypertension
Is Genetic Testing Important If I Have Kidney Cancer?
Katherine Nathanson, MD | Medical Genetics
What Treatment Options Are Available to Me For My Non-Clear Cell Kidney Cancer?
Lin Mei, MD | Hematology Oncology | Conference Co-Chair
Panel Discussion | Question and Answer
MODERATOR: Naomi Haas, MD | Hematology Oncology | Conference Chair
PANEL:
Daniel Lee, MD, MS | Urology | Conference Co-Chair
Lin Mei, MD | Hematology Oncology | Conference Co-Chair
Vivek Narayan, MD, MS | Hematology Oncology | Conference Co-Chair
Katherine Nathanson, MD | Medical Genetics
Aisha Shaikh, MBBS | Renal-Electrolyte and Hypertension
Glenn Sykes | Cancer Patient Advocate | Conference Co-Chair
Break
GENERAL SESSION TWO: MY CANCER SPREAD, WHAT SHOULD I KNOW ABOUT TREATMENT?
What Does the Treatment Landscape Look Like for Clear Cell Kidney Cancer?
Naomi Haas, MD | Hematology Oncology | Conference Chair
Kidney Cancer Research Consortium Trials
Ulka Vaishampayan, MBBS | University of Michigan Health
Finding Clinical Trials
Kate Barbour, MSc | National Clinical Trials Network
Surgery for Metastatic Kidney Cancer
Phil Pierorazio, MD | Urology | Conference Co-Chair
Imaging Approaches and Analyses Which Could Change How We Manage Your Kidney Cancer
Brian Shuch, MD | Urology | UCLA
What is a Biomarker and How Might Research Blood Samples Change the Future Management of Kidney Cancer?
Vivek Narayan, MD, MS | Hematology Oncology | Conference Co-Chair
Panel Discussion | Question and Answer
Panel Discussion
MODERATOR: Glenn Sykes | Cancer Patient Advocate | Conference Co-Chair
PANEL:
Kate Barbour, MSc | National Clinical Trials Network
Naomi Haas, MD | Hematology Oncology | Conference Chair
Vivek Narayan, MD, MS | Hematology Oncology | Conference Co-Chair
Phil Pierorazio, MD | Urology | Conference Co-Chair
Brian Shuch, MD | Urology | UCLA
Ulka Vaishampayan, MBBS | University of Michigan Health
Lunch
GENERAL SESSION 3: HOW DO I MAINTAIN MY QUALITY OF LIFE?
When Normal Changes
Glenn Sykes | Cancer Patient Advocate | Conf Co-Chair
Maintaining Positive Relationships with Family, Friends and Caregivers
Neal Niznan, MSW, LCSW | Oncology Social Work
Physical and Nutritional Health for RCC Patients
Aly-Khan A. Lalani (BSc (Hons), MD, FRCPC) | Bladder Cancer Canada
Management of Treatment Side Effects
Tarenne Carrington, CRNP | Hematology Oncology
Supportive Care During Treatment
Debra Kossman, PhD, CRNP | Hematology Oncology
Panel Discussion | Question and Answer
MODERATOR: Vivek Narayan, MD, MS | Hematology Oncology | Conference Co-Chair
PANEL:
Tarenne Carrington, CRNP | Hematology Oncology
Debra Kossman, PhD, CRNP | Hematology Oncology
Neal Niznan, MSW, LCSW | Oncology Social Work
Glenn Sykes | Cancer Patient Advocate | Conference Co-Chair
Closing Remarks
Naomi Haas, MD | Hematology Oncology | Conference Chair